- Treatment.com (TRUE) has developed a mobile app to integrate wearable health data into its AI engine for patient health assessments
- The app, known as Cara, integrates personal data from Apple Watch, Fitbit, Apple Health Kit and Google Health
- The aim is to provide improved real-time analysis, benchmarking and understanding of each consumer’s holistic health picture
- Cara will launch later this fall
- Treatment.com is a disruptive health care technology company harnessing the power of AI to help Canadians improve their health
- Treatment.com (TRUE) closed up 11.96 per cent trading at $5.15 per share
Treatment.com (TRUE) has developed a mobile app to integrate wearable health data into its AI engine for patient health assessments.
The AI engine integrates personalized medical history and demographic information and provides recommendations to prevent illness.
The app, known as Cara, integrates personal data from Apple Watch, Fitbit, Apple Health Kit and Google Health to provide enhanced real-time analysis, benchmarking and understanding of each consumer’s holistic health picture.
Treatment will partner with design agency Card79 to ensure Cara delivers a seamless user experience.
Cara will launch later this fall.
John Fraser, CEO of Treatment.com, commented,
“We spent a lot of time researching how consumers are thinking about their health and using technology to track many health metrics like exercise, calories, heart rate, weight, sleep, menstruation cycles, etc. All of this rich data is being captured in silos with no deeper analysis as to how it may impact your health. We see the future of our technology as being the most comprehensive view of your health, with the ability to show trends and make personalized recommendations that help consumers make better health decisions, and ultimately prevent illness in the long run.”
Treatment.com is a disruptive health care technology company harnessing the power of AI to help Canadians improve their health.
Treatment.com (TRUE) closed up 11.96 per cent trading at $5.15 per share.
